Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
0.960
-0.034 (-3.46%)
At close: Jul 2, 2024, 4:00 PM
0.956
-0.004 (-0.42%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $201.21 million as of July 2, 2024. Its market cap has increased by 6.12% in one year.
Market Cap
201.21M
Enterprise Value
197.03M
1-Year Change
6.12%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $201.21M, a decrease of -58.78%. That is a compound annual growth rate of -8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 208.30M | -10.83% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 217.61M |
| uniQure | 217.50M |
| NeuroPace | 217.49M |
| Century Therapeutics | 215.48M |
| Q32 Bio | 214.36M |
| Senseonics Holdings | 211.82M |
| Eliem Therapeutics | 211.54M |
| The Joint | 210.53M |